Evidence map›Paper›PMID 42782401›Full record

Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Psychological impact of hospital admission in cancer patients.

Paula Morillas-Martínez, Luis Gallart-Caballero, Natalia Pilar Pascual-delaFuente, Sofía Elena Ruffini-Egea, Fátima Mocha-Campillo, Pablo Trincado-Cobos, María Luna Monreal-Cepero, Sara Elena Campos-Ramírez, Pablo Gómez-Mugarza, Susana Barriendos-Sanz and 3 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Paula Morillas-MartínezOncology Department, University Hospital Miguel Servet, Zaragoza, Spain. paulamorillasm@gmail.com.ORCID https://orcid.org/0009-0002-6694-9545
Luis Gallart-CaballeroOncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
Natalia Pilar Pascual-delaFuenteOncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
Sofía Elena Ruffini-EgeaOncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
Fátima Mocha-CampilloOncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
Pablo Trincado-CobosOncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
María Luna Monreal-CeperoOncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
Sara Elena Campos-RamírezOncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
Pablo Gómez-MugarzaOncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
Susana Barriendos-SanzOncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
María Pilar Felices-LoberaOncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
Diego Casas-DezaAragon Health Research Institute (IISA), Zaragoza, Spain.
Marta Gascón-RuizOncology Department, University Hospital Miguel Servet, Zaragoza, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAnalyze the prevalence of anxiety and depression in hospitalized cancer patients and associated clinical and psychosocial factors.

methodsA single-center, prospective, observational study was conducted in the Oncology Department of Miguel Servet Hospital (HUMS). Patients completed Hospital Anxiety and Depression Scale (HADS), Duke-UNC Functional Social Support Questionnaire (DUKE), and Consumer Assessment of Healthcare Providers and Systems (CAHPS). Clinical and psychosocial variables were collected.

results166 patients were included. Prevalence of anxiety at admission was 47% (95% CI: 39-55%) and depression 43% (95% CI: 35-51%), decreasing at discharge to 40% (95% CI:32-48%) and 39% (95% CI:31-47%), respectively. Baseline anxiety was associated with anxiolytics (29.5% vs 13.6%; p = 0.012) and antidepressants use (25.6% vs 11.4%; p = 0.017); baseline depression with Eastern Cooperative Oncology Group Performance Status (ECOG) ≥ 2 (64.7% vs 42.1%; p = 0.022) and opioid (62% vs 41.1%; p = 0.008). At discharge, higher anxiety was associated with poorer patient-oncologist relationship (26.7% vs 12.1%; p = 0.022), and higher anxiety (r = -0.15, p = 0.01) and depression (r = -0.3, p = 0.001) with lower social support. At discharge, fatigue was associated with increased anxiety (36.7% vs 18.7%; p = 0.013) and depression (35.6% vs 19.6%; p = 0.028); pre-admission anxiolytics use, to greater anxiety (28.3% vs 14.3%; p = 0.034) and depression (27.1% vs 15.2%; p = 0.074); pre-admission antidepressants use (30.5% vs 9.8%; p = 0.001) and opioids (57.6% vs 39.1%; p = 0.026) with greater depression.

conclusionsHospitalized cancer patients show high prevalence of anxiety and depression. Poorer doctor-patient relationship, less social support, fatigue, and pre-admission anxiolytics use were associated with greater anxiety and depression; pre-admission antidepressants and opioids were associated with depression.

Indexed as

AnxietyDepressionHospitalizationNeoplasmsAdultAgedAnti-Anxiety AgentsAntidepressive AgentsFemaleHumansMaleMiddle AgedPrevalenceProspective StudiesPsychiatric Status Rating ScalesSocial SupportAnti-Anxiety AgentsAntidepressive AgentsAnxietyDepressionPsycho-oncologyQuality of careSocial support

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.